Search research articles
Contact Us
Filters
Showing results (51-60 of 72) with videos related to
Page
of 8
Sort By:
Scientific Reports
|
December 1, 2019
Exacerbation of ozone-induced pulmonary and systemic effects by β<sub>2</sub>-adrenergic and/or glucocorticoid receptor agonist/s
Andres R Henriquez, Samantha J Snow, Mette C Schladweiler, et al.
Toxicology
|
May 29, 2021
The dynamicity of acute ozone-induced systemic leukocyte trafficking and adrenal-derived stress hormones
Andres R Henriquez, Wanda Williams, Samantha J Snow, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
November 1, 2018
Beta-2 Adrenergic and Glucocorticoid Receptor Agonists Modulate Ozone-Induced Pulmonary Protein Leakage and Inflammation in Healthy and Adrenalectomized Rats
Andres R Henriquez, Samantha J Snow, Mette C Schladweiler, et al.
The Journal of Biological Chemistry
|
November 25, 1994
Enhanced peripheral glucose utilization in transgenic mice expressing the human GLUT4 gene
J L Treadway, D M Hargrove, N A Nardone, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 20, 2004
Potent and selective, sulfamide-based human beta 3-adrenergic receptor agonists
Robert L Dow, Ernest S Paight, Steven R Schneider, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 12, 2020
Advancing Palliative Care in Patients With CKD: From Ideas to Practice
Helen H-L Chiu, Donna M Murphy-Burke, Sarah A Thomas, et al.
Archives of Toxicology
|
April 22, 2019
The role of fuel type and combustion phase on the toxicity of biomass smoke following inhalation exposure in mice
Yong Ho Kim, Charly King, Todd Krantz, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 17, 2007
Discovery of potent and orally bioavailable heterocycle-based beta3-adrenergic receptor agonists, potential therapeutics for the treatment of obesity
Jennifer A Lafontaine, Robert F Day, Joe Dibrino, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 8, 2011
Discovery and evaluation of pyrazolo[1,5-a]pyrimidines as neuropeptide Y1 receptor antagonists
David A Griffith, Diane M Hargrove, Tristan S Maurer, et al.
Journal of Medicinal Chemistry
|
April 26, 2019
Discovery of Potent, Selective, and Short-Acting Peptidic V<sub>2</sub> Receptor Agonists
Kazimierz Wiśniewski, Steve Qi, John Kraus, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 72) with videos related to
Sort By:
Page
of 8
Scientific Reports
|
December 1, 2019
Exacerbation of ozone-induced pulmonary and systemic effects by β<sub>2</sub>-adrenergic and/or glucocorticoid receptor agonist/s
Andres R Henriquez, Samantha J Snow, Mette C Schladweiler, et al.
Toxicology
|
May 29, 2021
The dynamicity of acute ozone-induced systemic leukocyte trafficking and adrenal-derived stress hormones
Andres R Henriquez, Wanda Williams, Samantha J Snow, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
November 1, 2018
Beta-2 Adrenergic and Glucocorticoid Receptor Agonists Modulate Ozone-Induced Pulmonary Protein Leakage and Inflammation in Healthy and Adrenalectomized Rats
Andres R Henriquez, Samantha J Snow, Mette C Schladweiler, et al.
The Journal of Biological Chemistry
|
November 25, 1994
Enhanced peripheral glucose utilization in transgenic mice expressing the human GLUT4 gene
J L Treadway, D M Hargrove, N A Nardone, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 20, 2004
Potent and selective, sulfamide-based human beta 3-adrenergic receptor agonists
Robert L Dow, Ernest S Paight, Steven R Schneider, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 12, 2020
Advancing Palliative Care in Patients With CKD: From Ideas to Practice
Helen H-L Chiu, Donna M Murphy-Burke, Sarah A Thomas, et al.
Archives of Toxicology
|
April 22, 2019
The role of fuel type and combustion phase on the toxicity of biomass smoke following inhalation exposure in mice
Yong Ho Kim, Charly King, Todd Krantz, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 17, 2007
Discovery of potent and orally bioavailable heterocycle-based beta3-adrenergic receptor agonists, potential therapeutics for the treatment of obesity
Jennifer A Lafontaine, Robert F Day, Joe Dibrino, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 8, 2011
Discovery and evaluation of pyrazolo[1,5-a]pyrimidines as neuropeptide Y1 receptor antagonists
David A Griffith, Diane M Hargrove, Tristan S Maurer, et al.
Journal of Medicinal Chemistry
|
April 26, 2019
Discovery of Potent, Selective, and Short-Acting Peptidic V<sub>2</sub> Receptor Agonists
Kazimierz Wiśniewski, Steve Qi, John Kraus, et al.
Page
of 8